Skip to main content

2024 Annual Meeting - Agenda

KYACC 2024 Annual Conference

Thank you to our annual meeting sponsors

The Kentucky Academy of Cardiology will be holding its 20th Annual Meeting & Scientific Session, September 21, 2024 at the Marriott Louisville East in Louisville, Kentucky.

This is the premier educational and networking event for cardiologists and cardiovascular team members in the Commonwealth of Kentucky. This program is specifically designed for physicians, cardiac care associates, cardiovascular pharmacists, echo sonographers, nurses, and other practitioners with an emphasis on current practice trends within cardiovascular medicine.

Continuing Education information located after the agenda.

SATURDAY, SEPTEMBER 21, 2024

07:00 AM

Registration Opens

07:30 AM - 09:00 AM

Echo Machine Showcase, Posters, Exhibitors, and Breakfast

09:00 AM - 09:20 AM

Governor’s Address

Speaker: Dinesh K. Kalra, MD

Watch the Recording

09:20 AM - 10:15 AM

 Welcome: Current Concepts in Cardio-Oncology

Navigating The Cardiovascular Crossroads Through Oncologic Therapy. Provide an Overview of Cardiotoxicity in Cancer Therapies.

  • Discuss interactions between cancer, cancer therapy and the heart
  • Discuss the role of Cardio-Oncology; Biomarkers; Risk assessment, including the guidelines
  • Discuss Therapy, Management and Drug Interactions via sample case scenarios

Speaker: Tochukwu (Tochi) Okwuosa, DO, FACC, FAHA

10:15 AM - 10:40 AM

Break – Posters and Exhibits

10:40 AM - 11:00 AM

Honorable Maestro Award

Speaker: Mohammed Kazimuddin, MD

Watch the Recording

11:00 AM - 11:30 AM

Oral Abstract Presentations

Moderators: Andrew R. Kolodziej, MD, FACC; Steve Leung, MD

Watch - Enhancing an Inpatient Early Literacy Program Through Partnership, Access and Representation

Watch - Randomized Trials of Renal Denervation for Uncontrolled Hypertension

Watch - Trends in Lipoprotein(a) Testing within a Large Academic Health System

11:30 AM - 12:10 PM

Advocacy Update

Advocacy Speakers: Cory Meadows, KMA Director of Advocacy; Tricia Grodecki, MD; Michael Lawrence, ACC Director of State Governmental Affairs; Dinesh K. Kalra, MD

Moderator: Jillian Leung, PharmD

Watch the Recording

12:10 PM - 01:00 PM

 Assessment of Competency in Cardiovascular Medicine

Address the approach to competency-based education, during cardiology fellowship and beyond, and will provide updates on physician board certification and the application for a new cardiovascular medicine board.

  • Get updated on the status of the application for a new cardiovascular medicine board
  • Understand competency-based education and how to identify knowledge gaps
  • Recognize the importance of assessing competence for optimization of patient care

Speaker: Jeffrey Kuvin, MD

Watch the Recording

01:00 PM - 01:20 PM

Break with Exhibitors

01:20 PM - 02:40 PM

Aortic Stenosis: Calcium Scoring, Low-flow/Low-gradient, TAVR, Congenital


 Echocardiographic Evaluation of Aortic Stenosis Pre and Post Aortic Valve Replacement

This session will provide an overview of the echocardiographic evaluation of aortic stenosis in the pre-, intra-, and post-procedure settings. Acquiring key images, making accurate measurements, grading stenosis severity, and detecting procedural complications will be reviewed.

  • Review the echocardiographic evaluation of aortic stenosis
  • Grade the severity of aortic stenosis
  • Detect and evaluate complications post aortic valve intervention

Speaker: Peter Haigh, MD; Niki McKibben, BHS, RDCS

Watch the Recording


 Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome

Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome.

  • Understand fetal circulation and how alterations associated with congenital heart disease affects cardiac growth
  • Discuss indications and patient selection criteria for fetal aortic valvuloplasty
  • Describe outcomes of fetal aortic valvuloplasty with postnatal evaluation and follow up

Speaker: Adam Skaff, MD

Watch the Recording


 The Role of Cardiac CT in Pre-Procedural Planning

  • Discuss the current role of cardiac CT in TAVR procedure, patients and devices selection
  • Discuss the current role of cardiac CT in TMVR procedure, patients and devices selection
  • Discuss the current role of cardiac CT in LAAO procedure, patients and devices selection

Speaker: Amr Idris, MD

Watch the Recording


Cardio-Oncology


 Establishing and Maintaining a Multidisciplinary Amyloid Program

Triumph over cardiac amyloidosis: the importance of multidisciplinary approach to Cardiac Amyloid.

  • Highlight the Importance of cardiac Amyloid management with multidisciplinary approach
  • Describe the University of Kentucky Amyloid Alliance
  • Describe the roles of various specialists of the amyloid alliance in diagnosis and management of cardiac amyloidosis

Speaker: Andrew R. Kolodziej, MD, FACC


 HFpEF and Frailty/Malnourishment for Steven Heatherly

This session aims to provide an in-depth understanding of the complex interplay between Heart Failure with preserved Ejection Fraction (HFpEF), frailty, and malnourishment. Participants will gain insights into the pathophysiology, clinical features, diagnostic criteria, and management strategies for HFpEF in patients who are frail and malnourished. Through case studies, interactive discussions, and evidence-based approaches, healthcare providers will learn to optimize care for this vulnerable patient population.

  • Understand the relationship between HFpEF and frailty/malnourishment
  • Identify the clinical features and diagnostic criteria for HFpEF in patients with frailty and malnourishment
  • Evaluate the management strategies and treatment options for patients with HFpEF and concurrent frailty and malnourishment

Speaker: Steven Heatherly, MD, Ph.D., FACC

Watch the Recording


 Triumph Over Amyloidosis: A Case of Successful Dual Organ Transplant in a Patient With ATTR and AL Amyloidosis Through Multidisciplinary Care

During this session we will review the clinical course of a patient with both ATTR and AL amyloidosis who received a dual organ transplant. We will review pre and post transplant care in patients with amyloidosis and discuss the importance of a multi-disciplinary approach.

  • Understand the importance of a multidisciplinary approach in the evaluation of amyloidosis
  • Review pre-transplant evaluation and preparation in patients with amyloidosis
  • Learn about postoperative care and long-term management strategies in patients with amyloidosis

Speaker: Vasili Katsadouros, DO

Watch the Recording


New Pharmacotherapies, Drug-Induced Harm


 Injecting Safe Cardiovascular Risk Reductions with Incretin Mimetics

With more adults living with chronic health conditions and the expansion of medications focused on treatment and prevention of these conditions, the cardiology community is more focused on cardiometabolic disease and chronic health management. The use of glucagon-like peptide-1 receptor and gastric inhibitory polypeptide receptor agonists are growing in popularity, not only for diabetes management, but also weight management and cardiovascular risk reduction. While more cardiology clinicians are prescribing these agents recently, diabetes clinicians have been utilizing these agents for over a decade. It is important to appreciate the clinical experience, efficacy data, and safety profiles for these agents for our patients.

  • Describe the indications and efficacy data for use of GLP1R and GIP agonists
  • Evaluate the safety profiles for incretin mimetics to support safe and effective prescribing
  • Appreciate clinical practice pearls to improve patient response and tolerance to incretin mimetics

Speaker: Tina Claypool, PharmD, CDCES, BCACP, FKSHP

Watch the Recording


 The Heart’s Hidden Imposters: Cracking the Code of HFpEF Mimics

Identification and treatment of HFpEF mimics and safety considerations with treatment of certain HFpEF mimics.

  • Discuss HFpEF definition, diagnosis, and treatment
  • Identify and describe the definition, diagnosis, and treatment of certain cardiac HFpEF mimics
  • Describe the adverse events and safety considerations with treatment of HFpEF mimics

Speaker: Holly Tyson, PharmD

Watch the Recording


 You, Me, and Her Too: Management of HER2-Targeted Cardiotoxicities

Human Epidermal Growth Factor Receptor-2 (HER2) targeted therapies are common treatments used to manage and treat several oncologic malignancies. Since the approval of trastuzumab in 1998, patients with HER2-positive breast cancer have lived longer; however, the risk for adverse cardiac events has increased in patients treated with trastuzumab.

  • Explain the pathophysiologic mechanism of HER2-targeted cardiotoxicity
  • Describe risk stratification tools for HER2-targeted cardiotoxicity and monitoring protocols for such cardiotoxicity
  • Discuss management strategies to prevent HER2-targeted cardiotoxicity

Speaker: Aaron Adkisson, PharmD, BCCP

Watch the Recording


02:40 PM - 03:00 PM

Break with Exhibits, Posters, Echo Showcase

03:00 PM - 04:20 PM

Arrhythmias in Heart Failure


 Arrhythmias in the Failing Fontan Patient

  • Review which patients undergo the Fontan operation and its surgical variations
  • Review long-term outcomes in patients s/p Fontan, including arrhythmias and heart failure
  • Review noninvasive and invasive management strategies for Fontan patients with arrhythmias and HF

Speaker: Christopher Johnsrude, MD, MS

Watch the Recording


 Atrial Fibrillation and Heart Failure

Atrial fibrillation (AF) and heart failure (HF) frequently coexist. Both are associated with significant morbidity and mortality. Appropriate AF management in HF can significantly improve outcomes.

  • To recognize impact of AF on HF management
  • To acknowledge possible benefits of maintaining normal sinus rhythm in patients with AF
  • To acknowledge possible benefits of maintaining normal sinus rhythm in patients with HF

Speaker: Piotr Futyma

Watch the Recording


 Current State of Ventricular Arrhythmia Management

Ventricular tachycardia diagnosis and management for the non EP.

  • Understand role of new medications to treat EP
  • Be aware of role of stellate ganglion block in management of VT storm
  • Be aware of new technologies in pipeline that may change VT ablation

Speaker: Kevin Parrott, MD

Watch the Recording


 Device Therapy in Chronic Heart Failure

  • Review the patient selection criteria, technical considerations, and clinical data for ICD and CRT
  • Examine the clinical benefits of left bundle pacing in comparison to CRT therapy
  • Explore the potential roles of other devices, including CCM and autonomic modulation

Speakers: Karam Ayoub, MD

Watch the Recording


Cardiac PET/Stress CMR


 Chest Pain Guidelines – Role of CT and FFRCT

This session will delve into the latest chest pain guidelines, emphasizing the pivotal role of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT). Attendees will gain insights into how these advanced imaging modalities enhance diagnostic accuracy, guide treatment decisions, and improve patient outcomes in the management of chest pain.

  • Review the latest guidelines for the evaluation and management of chest pain, with a focus on how these guidelines incorporate the use of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT)
  • Analyze the role of coronary CTA in the diagnosis and risk stratification of patients presenting with chest pain, including its accuracy, diagnostic capabilities, and integration into clinical practice

Speaker: Mrin Shetty, MD

Watch the Recording


 CMR and Cardiomyopathy

Advanced Cardiac Imaging in General Clinical Practice.

  • Understand the Role of Advanced Cardiac Imaging (Coronary CTA and Cardiac MRI) in the Assessment of Coronary Artery Disease and Cardiomyopathy
  • Identify Appropriate Use and Guideline Indications for the Utilization and Implementation of Coronary CTA and Cardiac MRI in Clinical Practice
  • Integrate Coronary CTA and Cardiac MRI into Clinical Decision-Making for Risk Stratification and Prognostication

Speaker: Nicholas Biondi, DO

Watch the Recording


 PET for the Evaluation of Ischemic Heart Disease

Various non-invasive imaging modalities are available for evaluating patients with ischemic heart disease. This session focuses on the use of cardiac PET in ischemic heart disease.

  • Discuss differences between SPECT and PET for evaluation of IHD
  • Understand the use of PET in evaluating patients with suspected IHD
  • Demonstrate the utility of cardiac PET through case illustrations

Speaker: Talal Alnabelsi, MD

Watch the Recording


Pulmonary Hypertension: Guidelines, Medications


 Navigating Sotatercept: A Roadmap for Success

Explore critical aspects of initiating Sotatercept therapy with an emphasis on the referral process, the initial treatment phase and the nursing role in preventing treatment delays and minimizing patient harm.

  • Provide an overview of Sotatercept, highlighting its unique mechanism of action and potential impact on patient outcomes
  • Discuss the importance of patient education to streamline the referral process and enhance patient adherence
  • Outline the critical role of clear team communication with regards to preventing treatment delays and minimizing patient harm

Speaker: Elaine Major, BSN, RN


 Pulmonary Hypertension in Fontain Heart Disease: Not Just a Pulmonary Vascular Problem

Pediatric pulmonary hypertension definition, diagnostic algorithm, and treatment – updates from the 2024 World Symposium.

  • Define pulmonary hypertension in a pediatric patient
  • Review the diagnostic algorithm and risk stratification for children with PH
  • Describe the current treatment practices for children with PH

Speaker: Clayton Allen Smith Jr., MD

Watch the Recording


04:20 PM - 04:30 PM

Awards and Prizes

04:30 PM - 05:00 PM

FIT Jeopardy

Chair: Steve Leung, MD

How to Get Your Certificate

  1. Go to kyacc.cmecertificateonline.com
  2. Click on the 2024 KYACC Scientific Meeting link
  3. Choose the evaluation commensurate with your profession
  4. Evaluate the meeting
  5. Print, download, or save your certificate for your records
  6. If you lose your certificate, or need help, go to help.cmecertificateonline.com

Continuing Education

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLCand American College of Cardiology Kentucky Chapter. Amedco LLC is jointly accredited by theAccreditation Council for Continuing Medical Education (ACCME), the Accreditation Council forPharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to providecontinuing education for the healthcare team.

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians

Amedco LLC designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists & Pharmacy Technicians

Amedco LLC designates this activity for a maximum of 7.00 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

Nurses

Amedco LLC designates this activity for a maximum of 7.00 ANCC contact hours.

Other Professions

American Society of Radiologic Technologists (ASRT)

Before Approval: Application for Category A CE credit has been submitted for consideration to the ASRT.